Previous Article
Full text loading...
Therapeutic Research
No data available.
Please log in to see this content.
You have no subscription access to this content.
The full text of this article is not currently available.
ルストロンボパグの反復投与を行い観血的治療が可能であった高度血小板減少を伴う肝細胞癌の2 例
JPY
View Affiliations
ライフサイエンス出版
Abstract
Lusutrombopag has been covered by national health insurance in Japan, and now has been widely available for severe thrombocytopenia in the chronic liver disease patients. We experienced two cases of repeated treatment using lusutrombopag. Both of two patients had hepatocellular carcinoma with severe thrombocytopenia, and received repeated invasive treatments such as radiofrequency ablation and transcatheter arterial chemoembolization successfully, without severe bleeding, thrombosis or any serious adverse events. Repetitive administration of lusutrombopag was efficient and safe.
